CLONING AND FUNCTIONAL EXPRESSION OF THE HUMAN GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR

被引:163
|
作者
DILLON, JS
TANIZAWA, Y
WHEELER, MB
LENG, XH
LIGON, BB
RABIN, DU
YOOWARREN, H
PERMUTT, MA
BOYD, AE
机构
[1] MILES RES CTR, W HAVEN, CT USA
[2] WASHINGTON UNIV, SCH MED, DIV METAB, ST LOUIS, MO 63110 USA
关键词
D O I
10.1210/en.133.4.1907
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Truncated forms of glucagon-like peptide-1 are the most potent endogenous stimuli of insulin secretion and have powerful antidiabetogenic effects. To determine the structure and coupling mechanisms of the human GLP-1 receptor we have isolated two pancreatic islet cDNAs, encoding the 463 amino acid receptor and differing mainly in their 3' untranslated regions. The deduced amino acid sequence is 90% homologous with the rat GLP-1 receptor. Northern blot analysis shows expression of a single 2.7 kb transcript in pancreatic tissue. When expressed in COS-7 cells the recombinant receptor conferred specific, high affinity GLP-1(7-37) binding. GLP-1(7-37) increased intracellular cAMP in a concentration dependent manner and caused an increase in the free cytosolic calcium ([Ca2+]i) from an intracellular pool, characteristic of phospholipase C (PLC) activation. Thus, like the structurally related glucagon and parathyroid hormone receptors, the human GLP-1 receptor can activate multiple intracellular signaling pathways including adenylyl cyclase and PLC. Knowledge of the GLP-1 receptor structure will facilitate the development of receptor agonists and elucidation of the important role of GLP-1 in normal and disease states.
引用
收藏
页码:1907 / 1910
页数:4
相关论文
共 50 条
  • [41] Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
    Drucker, D. J.
    Rosen, C. F.
    DIABETOLOGIA, 2011, 54 (11) : 2741 - 2744
  • [42] SYSTEMATIC REVIEW ON COST-EFFECTIVENESS OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS
    Winberg, D.
    Shi, L.
    VALUE IN HEALTH, 2022, 25 (07) : S378 - S378
  • [43] Human Sperm Express the Receptor for Glucagon-like Peptide-1 (GLP-1), Which Affects Sperm Function and Metabolism
    Rago, Vittoria
    De Rose, Daniela
    Santoro, Marta
    Panza, Salvatore
    Malivindi, Rocco
    Ando, Sebastiano
    D'Agata, Rosario
    Aquila, Saveria
    ENDOCRINOLOGY, 2020, 161 (04)
  • [44] INTERACTIONS BETWEEN GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AND THE RECEPTOR FOR AGES (RAGE) IN DIABETIC NEPHROPATHY
    Sourris, K.
    Penfold, S.
    Wang, J.
    Cooper, M.
    Coughlan, M.
    NEPHROLOGY, 2014, 19 : 61 - 61
  • [45] Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review
    Halloum, Wael
    Dughem, Yousef Al
    Beier, Dagmar
    Pellesi, Lanfranco
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [46] Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas
    Vesterinen, Tiina
    Peltola, Elina
    Leijon, Helena
    Hannula, Paeivi
    Huhtala, Heini
    Makinen, Markus J.
    Nieminen, Lasse
    Pirinen, Elina
    Ronty, Mikko
    Soderstrom, Mirva
    Jaatinen, Pia
    Arola, Johanna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [47] Expression of the glucagon-like peptide-1 receptor and glucokinase in human brain
    Roncero, I
    Alvarez, E
    Chowen, J
    Rabano, A
    Garcia-Cuartero, B
    Sanz, C
    Blázquez, E
    DIABETOLOGIA, 2000, 43 : A30 - A30
  • [48] Comment on: "Glucagon-like peptide-1 receptor expression in the human eye"
    Simo, Rafael
    Hernandez, Cristina
    DIABETES OBESITY & METABOLISM, 2019, 21 (02): : 446 - 447
  • [49] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
    Li, Ya-Kun
    Ma, Dong-Xia
    Wang, Zhi-Min
    Hu, Xiao-Fan
    Li, Shang-Lin
    Tian, Hong-Zhe
    Wang, Meng-Jun
    Shu, Yan-Wen
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 102 - 111
  • [50] Somatostatin is a major, paracrine regulator of glucagon-like peptide-1 (GLP-1) secretion
    Hansen, L
    Mineo, H
    Bisgaard, T
    Jorgensen, PN
    Holst, JJ
    DIABETOLOGIA, 1997, 40 : 498 - 498